mortality/aging
• between 12 and 30 weeks of age, 70% of transgenic mice exhibit signs of illness - decreased activity, weight loss and breathing difficulty - and within a week become acutely moribund and die or must be euthanized
|
immune system
• moribund mice have massive splenomegaly
|
• by 6 weeks of age, all transgenic mice exhibit peripheral blood lymphocytosis, with lymphocyte counts averaging 31, 694 +/- 3, 267 /ul of blood versus 7, 983 +/- 503/ ul of control blood
• between 12 and 30 weeks of age, 70% of transgenic mice demonstrate progression of earlier lymphocytosis, with lymphocyte counts averaging 186,000 +/- 32,433/ul (range 46,000 - 606,000/ul) of blood
• peripheral blood smears from ill mice contain large numbers of lymphocytes, some with blast-like features and prominent nucleoli
|
• early lymphocytosis in transgenic mice is due to expansion primarily of functional - in terms of target cell lysis and induced interferon gamma secretion - DX5+CD3-Ly49+ natural killer (NK) cells
|
• the early, benign expansion of CD8+CD44hiLy6c+ T cells observed in all transgenic mice is of polyclonal origin
• whereas absolute numbers of peripheral CD4+ T cells are comparable in 6 week old transgenic and control littermates, the number of CD8+ T cells is 10-fold greater in transgenic than in control mice
• flow cytometric analysis of lymphocytes from 22 affected (moribund) mice revealed the expanded population consistently bears the (somewhat heterogeneous) marker signature: CD3+TCR-beta+CD2+CD5+CD44+CD8+/-DX5mixed, although DX5+CD3- NK cells remain elevated
|
• because of the expansion of the CD8+ T cell compartment, the ratio of CD4+ to CD8+ T cells is dramatically skewed toward the CD8+ population in transgenic mice (0.59 +/- 0.04 versus 3.26 +/- 0.1 in controls)
|
• early lymphocytosis of transgenic mice is characterized by a secondary expanded subpopulation bearing the marker signature of memory T cells: CD44hi CD62LloCD69-Ly6chi
|
• mice with highly elevated lymphocyte counts have expansion of the splenic white pulp
|
• transgenic mice that do not exhibit late clonal lymphocyte expansion nonetheless develop multiorgan lymphocytic infiltration
• mice with highly elevated lymphocyte counts have lymphocyte infiltration of the peritoneum and intraabdominal organs
|
• mice with highly elevated lymphocyte counts have lymphadenopathy with disruption of the normal nodal architecture
|
• large numbers of both CD3+ T lymphocytes and NK cells invade the spleens of ill mice
|
dermatitis
(
J:67478
)
• mice with highly elevated lymphocyte counts exhibit skin inflammation characterized by heavy infiltration of the skin, primarily the dermis, by CD3+ lymphocytes and by mast cell infiltration
|
hematopoietic system
• moribund mice have massive splenomegaly
|
• large numbers of both CD3+ T lymphocytes and NK cells invade the bone marrow of ill mice
|
• by 6 weeks of age, all transgenic mice exhibit peripheral blood lymphocytosis, with lymphocyte counts averaging 31, 694 +/- 3, 267 /ul of blood versus 7, 983 +/- 503/ ul of control blood
• between 12 and 30 weeks of age, 70% of transgenic mice demonstrate progression of earlier lymphocytosis, with lymphocyte counts averaging 186,000 +/- 32,433/ul (range 46,000 - 606,000/ul) of blood
• peripheral blood smears from ill mice contain large numbers of lymphocytes, some with blast-like features and prominent nucleoli
|
• early lymphocytosis in transgenic mice is due to expansion primarily of functional - in terms of target cell lysis and induced interferon gamma secretion - DX5+CD3-Ly49+ natural killer (NK) cells
|
• the early, benign expansion of CD8+CD44hiLy6c+ T cells observed in all transgenic mice is of polyclonal origin
• whereas absolute numbers of peripheral CD4+ T cells are comparable in 6 week old transgenic and control littermates, the number of CD8+ T cells is 10-fold greater in transgenic than in control mice
• flow cytometric analysis of lymphocytes from 22 affected (moribund) mice revealed the expanded population consistently bears the (somewhat heterogeneous) marker signature: CD3+TCR-beta+CD2+CD5+CD44+CD8+/-DX5mixed, although DX5+CD3- NK cells remain elevated
|
• because of the expansion of the CD8+ T cell compartment, the ratio of CD4+ to CD8+ T cells is dramatically skewed toward the CD8+ population in transgenic mice (0.59 +/- 0.04 versus 3.26 +/- 0.1 in controls)
|
• early lymphocytosis of transgenic mice is characterized by a secondary expanded subpopulation bearing the marker signature of memory T cells: CD44hi CD62LloCD69-Ly6chi
|
• mice with highly elevated lymphocyte counts have expansion of the splenic white pulp
|
• transgenic mice that do not exhibit late clonal lymphocyte expansion nonetheless develop multiorgan lymphocytic infiltration
• mice with highly elevated lymphocyte counts have lymphocyte infiltration of the peritoneum and intraabdominal organs
|
neoplasm
• molecular analysis of Tcrb gene rearrangements defined the late expanded lymphocyte populations of 48% (9/19) of ill transgenic mice as clonal, indicative of T-cell leukemia
(J:67478)
• flow cytometric analysis of lymphocytes from 2 affected (moribund) mice revealed an expanded population of CD3-TCR-beta-CD8-CD4-DX5+ cells proposed to represent NK cell leukemias
(J:67478)
• ~30% of transgenic mice develop clonal expansion of NK/T lymphocytes in multiple tissues that progresses to acute lymphoblastic leukemia (NK/T ALL)
(J:97873)
|
liver/biliary system
• mice with highly elevated lymphocyte counts have liver involvement characterized by perivascular and sinusoidal lymphocyte infiltration
|
• moribund mice have massive hepatomegaly
|
respiratory system
• mice with highly elevated lymphocyte counts have lung involvement ranging from heavy but confined infiltration around blood vessels to generalized infiltration involving the alveolar walls
|
integument
dermatitis
(
J:67478
)
• mice with highly elevated lymphocyte counts exhibit skin inflammation characterized by heavy infiltration of the skin, primarily the dermis, by CD3+ lymphocytes and by mast cell infiltration
|
• all mice with this transgene develop progressive alopecia beginning at 4-6 weeks of age, affecting initially the head and forelimbs and eventually 50-90% of the skin surface
|
growth/size/body
• moribund mice have massive hepatomegaly
|
• moribund mice have massive splenomegaly
|